Winner Medical Announces to Acquire 55% Stake in Zhejiang Longterm Medical for US $108.2 Million

Winner Medical Co., Ltd.

PR96267

 

SHENZHEN, China, May 31, 2022 /PRNewswire=KYODO JBN/ --

 

On April 10 Winner Medical announced that it has signed a definitive agreement

to acquire 55% stake in Zhejiang Longterm Medical Technology Co., Ltd. for US

$108.2 million.

 

Winner Medical believes that the acquisition aligns with the company's strategy

to become the industry leader in the advanced wound care market. Winner Medical

and Longterm Medical will benefit from the economy of scale and synergy

generation in terms of overseas and domestic client base, market channels,

products, R&D and manufacturing.

 

Longterm Medical develops, produces and sells advanced wound care products, and

has been the market leader in advanced wound care industry in China. In 2021,

Longterm Medical generated a total sales revenue of more than US $52 million,

of which the revenue from advanced wound care and ostomy products contributed

more than US $41.6 million.

 

It has been 10 years since Longterm Medical was established. while Winner

Medical has a history of 31 years. Through post acquisition integration and

synergy generation, the two companies as a whole are expected to gain larger

market share and generate higher revenue growth.

 

In terms of domestic sales channels, Longterm Medical serves more than 600

hospitals, and Winner Medical covers more than 4,000 hospitals in China. The

two companies will work together closely and offer comprehensive one-stop

services and are committed to becoming the first choice for doctors, nurses and

patients. In addition, Winner Medical will also work with Longterm Medical to

develop home health care solutions for patients and consumers.

 

Global advanced wound care is a significant and growing market segment, while

the domestic industry concentration is expected to increase.  According to the

BIS Research Report, the global advanced wound care market is reached US $5.85

billion in 2020 and is expected to reach US $7.23 billion in 2027. Both Winner

Medical and Longterm Medical are the leaders in China market of advanced wound

care dressings, this acquisition will promote the complementary advantages of

both parties' global medical business,  further enhance Winner as the leader in

advanced wound care, while core value is leveraging technologies to improve

clinical outcomes and healthcare economics, and together,  a more comprehensive

solution to improve patients' lives worldwide.

 

For more information, please visit: https://www.winnermedical.com/

 

SOURCE: Winner Medical Co., Ltd.

 

Image Attachments Links:

 

   Link: http://asianetnews.net/view-attachment?attach-id=422438

 

   Caption: Winner Medical Announces to Acquire 55% Stake in Zhejiang Longterm Medical for

US $108.2 Million

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中